| 1 |
Gilbert DN. Nebulized antibiotics for multidrug-resistant ventilator-associated pseudomonas aeruginosa pneumonia[J]. Crit Care Med, 2019, 47(6): 880-881.
|
| 2 |
孙 康，李王平，潘 蕾，等. 医院获得性铜绿假单胞菌肺炎危险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(2): 166-170.
|
| 3 |
Fangous MS, Gosset P, Galakhoff N, et al. Priming with intranasal lactobacilli prevents Pseudomonas aeruginosa acute pneumonia in mice[J]. BMC Microbiol, 2021, 21(1): 195.
|
| 4 |
Torres A, Niederman MS. Too much or too little empiric treatment for pseudomonas aeruginosa in community-acquired pneumonia？[J]. Ann Am Thorac Soc, 2021, 18(9): 1456-1458.
|
| 5 |
Bassetti M, Echols R, Matsunaga Y, et al. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial[J]. Lancet Infect Dis, 2021, 21(2): 226-240.
|
| 6 |
Markwitz P, Olszak T, Gula G, et al. Emerging phage rsistance in pseudomonas aeruginosa PAO1 is accompanied by an enhanced heterogeneity and reduced virulence[J]. Viruses, 2021, 13(7): 1332.
|
| 7 |
中华医学会呼吸病学分会感染学组. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J]. 中华结核和呼吸杂志，2018, 41(4): 255-280.
|
| 8 |
Bassetti M, Vena A, Russo A, et al. Rational approach in the management of pseudomonas aeruginosa infections[J]. Curr Opin Infect Dis, 2018, 31(6): 578-586.
|
| 9 |
Damale MG, Patil R, Ansari SA, et al. Insilico structure based drug design approach to find potential hits in ventilator-associated pneumonia caused by Pseudomonas aeruginosa[J]. Comput Biol Med, 2022, 146: 105597.
|
| 10 |
Ryan MP, Adley CC. Sphingomonas paucimobilis: a persistent Gram-negative nosocomial infectious organism[J]. J Hosp Infect, 2010, 75(3): 153-157.
|
| 11 |
Maurice NM, Bedi B, Sadikot RT. Pseudomonas aeruginosa biofilms：Host response and clinical implications in lung infections[J]. Am J Respir Cell Mol Biol, 2018, 58(4): 428-439.
|
| 12 |
LeBlanc BW, Lefort CT. A mouse model of pseudomonas aeruginosa pneumonia[J]. Methods Mol Biol, 2021, 2321: 53-61.
|
| 13 |
李 霖，黄文治，乔 甫. 耐碳青霉烯类铜绿假单胞菌血流感染患者的预后及其影响因素研究[J]. 华西医学，2023, 38(3): 352-357.
|
| 14 |
Guan J, Wang Z, Liu X, et al. IL-6 and IL-10 closely correlate with bacterial bloodstream infection[J]. Iran J Immunol, 2020, 17(3): 185-203.
|
| 15 |
Hui-Heng L, Jun-Sheng W, Jin-Zhou L, et al. LPS induced PCT production via TLR-4/NF-кB passway：it is the difference of G－/G＋ bacteremia rats[J]. Cytokine, 2021, 137: 155317.
|
| 16 |
Lien F, Lin HS, Wu YT, et al. Bacteremia detection from complete blood count and differential leukocyte count with machine learning: complementary and competitive with C-reactive protein and procalcitonin tests[J]. BMC Infect Dis, 2022, 22(1): 287.
|
| 17 |
Yang X, Zeng J, Yu X, et al. PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection[J]. Ann Clin Microbiol Antimicrob, 2023, 22(1): 103.
|
| 18 |
Munsell MK, Fadelu T, Stuver SO, et al. The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients[J]. J Cancer Res Clin Oncol, 2023, 149(8): 5193-5204.
|
| 19 |
Kobayashi T, Iwatani S, Hirata A, et al. Rapid changes in serum IL-6 levels in preterm newborns with Gram-negative early-onset sepsis[J]. Cytokine, 2021，138: 155371.
|
| 20 |
Medina-Vera I, Sanchez-Tapia M, Noriega-López L, et al. A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes[J]. Diabetes Metab, 2019, 45(2): 122-131.
|
| 21 |
von Dach E, Albrich WC, Brunel AS, et al. Effect of C-Reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: A randomized clinical trial[J]. JAMA, 2020, 323(21): 2160-2169.
|
| 22 |
Banzhaf M, Resendis-Antonio O, Zepeda-Mendoza ML. Uncovering the dynamic mechanisms of the pseudomonas aeruginosa quorum sensing and virulence networks using boolean modelling[J]. IEEE Trans Nanobioscience, 2020, 19(3): 394-402.
|
| 23 |
牛志莹. ICU病房细菌耐药性监测[J]. 包头医学院学报，2018, 34(1): 55-56.
|
| 24 |
González-Vázquez MC, Rocha-Gracia R, Carabarín-Lima A, et al. Location of OprD porin in Pseudomonas aeruginosa clinical isolates[J]. APMIS, 2021, 129(4): 213-224.
|
| 25 |
Goto A, Komiya K, Umeki K, et al. Impact of Pseudomonas aeruginosa coverage on the prognosis of elderly patients with community-acquired pneumonia[J]. J Infect Chemother, 2023, 29(1): 55-60.
|
| 26 |
中华医学会呼吸病学分会感染学组. 中国铜绿假单胞菌下呼吸道感染诊治专家共识(2022年版)[J]. 中华结核和呼吸杂志，2022, 45(8): 739-752.
|